Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20044065HPVENSG00000004864.14protein_codingSLC25A13NoNo10165Q9UJS0
TVIS20023660HPVENSG00000004864.14protein_codingSLC25A13NoNo10165Q9UJS0
TVIS20039697HPVENSG00000004864.14protein_codingSLC25A13NoNo10165Q9UJS0
TVIS20068969HPVENSG00000004864.14protein_codingSLC25A13NoNo10165Q9UJS0
TVIS20061703HPVENSG00000004864.14protein_codingSLC25A13NoNo10165Q9UJS0
TVIS20061774HPVENSG00000004864.14protein_codingSLC25A13NoNo10165Q9UJS0
TVIS20032012HPVENSG00000004864.14protein_codingSLC25A13NoNo10165Q9UJS0
TVIS44005354HTLV-1ENSG00000004864.14protein_codingSLC25A13NoNo10165Q9UJS0
TVIS44049138HTLV-1ENSG00000004864.14protein_codingSLC25A13NoNo10165Q9UJS0
TCGA Plot Options
Drug Information
GeneSLC25A13
DrugBank IDDB00128
Drug NameAspartic acid
Target IDBE0000277
UniProt IDQ9UJS0
Regulation Type
PubMed IDs17213189; 17591776; 17237342; 17354380; 17228780
CitationsContreras L, Gomez-Puertas P, Iijima M, Kobayashi K, Saheki T, Satrustegui J: Ca2+ Activation kinetics of the two aspartate-glutamate mitochondrial carriers, aralar and citrin: role in the heart malate-aspartate NADH shuttle. J Biol Chem. 2007 Mar 9;282(10):7098-106. Epub 2007 Jan 9.@@Saheki T, Iijima M, Li MX, Kobayashi K, Horiuchi M, Ushikai M, Okumura F, Meng XJ, Inoue I, Tajima A, Moriyama M, Eto K, Kadowaki T, Sinasac DS, Tsui LC, Tsuji M, Okano A, Kobayashi T: Citrin/mitochondrial glycerol-3-phosphate dehydrogenase double knock-out mice recapitulate features of human citrin deficiency. J Biol Chem. 2007 Aug 24;282(34):25041-52. Epub 2007 Jun 25.@@Satrustegui J, Pardo B, Del Arco A: Mitochondrial transporters as novel targets for intracellular calcium signaling. Physiol Rev. 2007 Jan;87(1):29-67.@@Ikeda S: [Adult-onset citrullinemia]. Brain Nerve. 2007 Jan;59(1):59-66.@@Ikeda S: [Adult-onset citrullinemia]. No To Shinkei. 2007 Jan;59(1):59-66.
GroupsApproved; Nutraceutical
Direct ClassificationAspartic acid and derivatives
SMILESN[C@@H](CC(O)=O)C(O)=O
PathwaysLesch-Nyhan Syndrome (LNS); Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Xanthinuria Type I; Hyperornithinemia with Gyrate Atrophy (HOGA); Purine Nucleoside Phosphorylase Deficiency; Carnosinuria, Carnosinemia; Tyrosine Metabolism; Disulfiram Action Pathway; Hyperprolinemia Type II; Glutamate Metabolism; Adenine Phosphoribosyltransferase Deficiency (APRT); Mercaptopurine Action Pathway; Argininosuccinic Aciduria; L-Arginine:Glycine Amidinotransferase Deficiency; Xanthine Dehydrogenase Deficiency (Xanthinuria); Tyrosinemia Type I; Hyperinsulinism-Hyperammonemia Syndrome; Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency); Mitochondrial DNA Depletion Syndrome; Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency; Carbamoyl Phosphate Synthetase Deficiency; Hyperprolinemia Type I; Myoadenylate Deaminase Deficiency; Homocarnosinosis; Malate-Aspartate Shuttle; Arginine and Proline Metabolism; Purine Metabolism; Gout or Kelley-Seegmiller Syndrome; Adenylosuccinate Lyase Deficiency; Ammonia Recycling
PharmGKBPA448494
ChEMBLCHEMBL274323